| Code | 3608E | ||||||||||
| MA number | EU/1/21/1608/011 | ||||||||||
| Product Form: | sol inj 4x3 ml/2,4 mg (pero napl. FlexTouch + 12 ihiel) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Novo Nordisk A/S, Denmark | ||||||||||
| Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | pre-filled pen | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10b fixed combination application |
| MA issued: | 06.01.2022 |
| Validity: | 06.01.2027 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | Yes |
| Data update: | 18.05.2023 |
